Dr Nicole Dmochowska is an early-career Research Fellow whose research focuses on developing techniques and agents to enhance tumour mapping for improved cancer treatment, with a strong emphasis on clinical translation. She collaborates closely with Adelaide-based Ferronova to develop iron oxide contrast agents for improved tumour delineation on MRI. Notably, her work contributed to the development of second-generation FerroTrace-FAPi (WO/2022/241506, Mapping Nanoparticles), which is being prepared for first-in-human trials. In 2022, Nicole was awarded an MTPConnect Researcher Exchange and Development within Industry Fellowship, undertaking a year-long placement with Ferronova to gain industry expertise in clinical translation and... Read more
About me
Dr Nicole Dmochowska is an early-career Research Fellow whose research focuses on developing techniques and agents to enhance tumour mapping for improved cancer treatment, with a strong emphasis on clinical translation. She collaborates closely with Adelaide-based Ferronova to develop iron oxide contrast agents for improved tumour delineation on MRI. Notably, her work contributed to the development of second-generation FerroTrace-FAPi (WO/2022/241506, Mapping Nanoparticles), which is being prepared for first-in-human trials. In 2022, Nicole was awarded an MTPConnect Researcher Exchange and Development within Industry Fellowship, undertaking a year-long placement with Ferronova to gain industry expertise in clinical translation and commercialisation.
Nicole completed her PhD in Medicine at the University of Adelaide and the South Australian Health and Medical Research Institute in 2020 before joining the Future Industries Institute as a research associate. Her PhD focused on developing PET imaging tracers to target intestinal inflammation and fibrosis in a murine model of inflammatory bowel disease. During this time, she was awarded the William T. Southcott Nuclear Medicine Scholarship. From 2019 to 2024, Nicole served as a board member of the Australian Society of Molecular Imaging, contributing to the advancement of multidisciplinary molecular imaging research. She is also an Editorial Board Member for Discover Imaging (Springer Nature). Passionate about mentoring the next generation of women in STEM, Nicole is actively involved with the South Australian Academy for Gender Equity in STEM.
About me
Editorial board member of Discover Imaging (Springer Nature)
Board member of the Australian Society of Molecular Imaging
About me
Doctor of Philosophy (Medicine) University of Adelaide
Bachelor of Health Scineces, First Class Honours, majoring in Pharmacology University of Adelaide
Bachelor of Science, majoring in Chemistry and Pharmacology University of Adelaide
Research
Excludes commercial-in-confidence projects.
Preclinical investigation of an ultrabright indocyanine green nanoformulation towards improved intraoperative fluorescence-guided surgery of pancreatic tumours, Tour de Cure Ltd, 01/01/2024 - 04/09/2025
Preclinical validation of a new molecular magnetic resonance imaging of glioblastoma towards improved image-guided treatment, Tour de Cure Ltd, 01/07/2023 - 01/07/2024
FAPi-MRI towards Better target delineation of high-grade Gliomas, Neurosurgical Research Foundation, 30/08/2021 - 31/08/2022
Research
Research outputs for the last seven years are shown below. Some long-standing staff members may have older outputs included. To see earlier years visit ORCID or Scopus
Open access indicates that an output is open access.
| Year | Output |
|---|---|
| 2024 |
Open access
1
|
| 2023 |
Open access
6
6
1
|
| 2023 |
Open access
6
5
|
| 2022 |
5
5
5
|
| 2022 |
13
10
4
|
| 2020 |
Open access
6
7
|
| 2019 |
Open access
28
27
49
|
| 2019 |
Open access
12
11
3
|
| 2018 |
Open access
37
26
8
|
Research
| Details | Registry | Status |
|---|---|---|
|
Thierry, Benjamin; Nelson, Melanie Ruth Maria; Milanova, Valentina; Dmochowska, Nicole; Pham, Thi Hanh Nguyen; Hawkett, Brian Stanley |
World | Filed |
External engagement & recognition
| Organisation | Country |
|---|---|
| Dana-Farber Cancer Institute | UNITED STATES |
| Ferronova | AUSTRALIA |
| Harvard University | UNITED STATES |
| Purdue University | UNITED STATES |
| Royal Adelaide Hospital | AUSTRALIA |
| South Australian Health and Medical and Research Institute (SAHMRI) | AUSTRALIA |
| University of Adelaide | AUSTRALIA |
| University of South Australia | AUSTRALIA |
| University of Sydney | AUSTRALIA |
| Western Sydney University | AUSTRALIA |
External engagement & recognition
| Engagement/recognition | Year |
|---|---|
FellowshipResearcher Exchange and Development within Industry Fellowship |
2023 |
Secretary of the BoardAustralian Society of Molecular Imaging |
2023 |
FellowshipResearcher Exchange and Development within Industry Fellowship |
2022 |
Secretary of the BoardAustralian Society of Molecular Imaging |
2022 |
Board MemberAustralian Society of Molecular Imaging |
2021 |
Secretary of the BoardAustralian Society of Molecular Imaging |
2021 |
Alavi-Mandell Award - Highly commended paperSociety of Nuclear Medicine and Molecular Imaging |
2020 |
Board MemberAustralian Society of Molecular Imaging |
2020 |
Board MemberAustralian Society of Molecular Imaging |
2019 |
Teaching & student supervision
Supervisions from 2010 shown
| Thesis title | Student status |
|---|---|
| 110450 - Development of a theranostic agent for image-guided and radiosensitisation of pancreatic cancer | Current |
| 111188 - Development of brain tumour-targeting ICG nanoformulations for fluorescence-guided neurosurgery | Current |
| New radiobiological insights using a microphysiological device enabling long-term culture of patient-derived brain tumour tissue slices and cerebral organoid slices | Current |
| Next generation bioengineered in vitro tumour models | Current |
| Systematic characterisation of existing and new models of the vaginal mucosa and their application to assess the vaginal delivery of nanomedicine | Current |
| A nanomedicine approach for immune checkpoint inhibition: towards better and safer cancer immunotherapy | Completed |
